Cevimeline Ophthalmic Solution (BioTheraVision)

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameCevimeline Ophthalmic Solution (BioTheraVision)

Drug Alias NameBVT-100

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMuscarinic acetylcholine receptor M3 agonistsMuscarinic acetylcholine receptor M1 agonists

TargetsMuscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M1

Therapy Area/IndicationsXerophthalmia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwanAustralia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBioTheraVision Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsXerophthalmia

Inactive IndicationsN/A

ATC CodeN/A